Jaguar Health, Inc. (JAGX) Insider Trading

Over the last 6 months, 7 institutions increased and 2 reduced their position (13F).

Insider Activity

Sentiment
50/100
Buys (3m)
0
Sells (3m)
0
Net (3m)
$0
Insider trades by month Buys Sells
Mar
Jul
Jun
Mar
Jan
Apr
Context3-month price -91.1%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Mar 12, 2026MICEK JOHNdirectorGrant7,377
Jan 21, 2026Wolin Jonathan S.officer: See RemarksGrant11,740
Jan 21, 2026CONTE LISA Adirector, officer: See RemarksGrant28,592
Jan 21, 2026King Steven R.officer: See RemarksGrant11,740
Dec 15, 2025Siegel Jonathan B.directorGrant7,377
Dec 15, 2025Jayasuriya AnuladirectorGrant5,870
Dec 15, 2025Lizak Carol R.officer: Chief Financial OfficerGrant11,740
Dec 15, 2025Chaturvedi Pravin Rofficer: Chief Scientific OfficerGrant11,740
Dec 15, 2025BOCHNOWSKI JAMES JdirectorGrant6,363
Jun 26, 2025MICEK JOHNdirectorGrant9,462$5.55
Jun 26, 2025MICEK JOHNdirectorGrant18,262$2.70
Jun 26, 2025Siegel Jonathan B.directorGrant9,462$5.55
Jun 26, 2025BOCHNOWSKI JAMES JdirectorGrant28,388$5.55
Jun 26, 2025BOCHNOWSKI JAMES JdirectorGrant54,786$2.70
Jun 26, 2025King Steven R.officer: See RemarksGrant3,785$5.55
Jun 26, 2025King Steven R.officer: See RemarksGrant7,304$2.70
Jun 26, 2025Chaturvedi Pravin Rofficer: Chief Scientific OfficerGrant3,785$5.55
Jun 26, 2025Chaturvedi Pravin Rofficer: Chief Scientific OfficerGrant7,304$2.70
Jun 26, 2025Wolin Jonathan S.officer: See RemarksGrant9,462$5.55
Jun 26, 2025Wolin Jonathan S.officer: See RemarksGrant18,262$2.70
Jun 26, 2025CONTE LISA Adirector, officer: CEO and PresidentGrant9,462$5.55
Jun 26, 2025CONTE LISA Adirector, officer: CEO and PresidentGrant18,262$2.70
Jun 26, 2025Siegel Jonathan B.directorGrant18,262$2.70
May 20, 2025CONTE LISA Adirector, officer: CEO and PresidentOption2
May 20, 2025King Steven R.officer: See RemarksOption1
Apr 2, 2025Siegel Jonathan B.directorBuy9,000$5.55
Apr 2, 2025MICEK JOHNdirectorBuy9,000$5.55
Apr 2, 2025King Steven R.officer: See RemarksBuy3,600$5.55
Apr 2, 2025CONTE LISA Adirector, officer: CEO and PresidentBuy9,000$5.55
Apr 2, 2025Wolin Jonathan S.officer: See RemarksBuy9,000$5.43

Source: JAGX SEC Form 4 filings, latest Mar 12, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their JAGX positions over the last 6 months (SEC Form 13F).

Increased
7
New positions
7
Reduced
2
Sold out
5
Largest moves
InstitutionActionSharesFiled
UBS GROUP AGIncreased113KMay 5, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased110KMay 15, 2026
GEODE CAPITAL MANAGEMENT, LLCNew Position24KFeb 9, 2026
DRW SECURITIES, LLCReduced18KFeb 12, 2026
HRT FINANCIAL LPNew Position15KMay 14, 2026
TWO SIGMA SECURITIES, LLCNew Position13KMay 15, 2026
XTX TOPCO LTDNew Position12KFeb 17, 2026
UBS GROUP AGIncreased6KJan 29, 2026
TOWER RESEARCH CAPITAL LLC (TRC)Increased4KFeb 17, 2026
SBI SECURITIES CO., LTD.Increased3KApr 28, 2026
TOWER RESEARCH CAPITAL LLC (TRC)Reduced2KMay 15, 2026
ROYAL BANK OF CANADAUnchanged702May 15, 2026
ROYAL BANK OF CANADAUnchanged702Feb 17, 2026
SBI SECURITIES CO., LTD.Unchanged220Feb 3, 2026
WELLS FARGO & COMPANY/MNNew Position200Jul 8, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.